Supplements
The Lens Replacement Journey
Thomas Kohnen
Published: Monday, February 1, 2021
In this supplement, published by EuroTimes in association with the ESCRS Education Forum, experts share their perspectives on optimizing MGD diagnosis and treatment. The supplement includes insights from Thomas Kohnen, Germany; Arthur Cummings, Ireland; Francesco Carones, Italy; and Detlev R.H. Breyer, Germany. Supported by an unrestricted educational grant from Alcon (Gold) and BVI (Bronze).
Tags: MGD Diagnosis
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.